News & Events Year None2022202120202019201820172016201520142013201220112009 09/27/22 REGENXBIO Announces Presentation at Chardan's 6th Annual Genetic Medicines Conference 09/26/22 REGENXBIO Announces Upcoming Presentations During the American Academy of Ophthalmology 2022 Annual Meeting 09/06/22 REGENXBIO to Participate in Upcoming Investor Conferences 08/31/22 REGENXBIO Presents Additional Positive Interim Data from the Phase I/II/III CAMPSIITE™ Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 08/23/22 REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 08/10/22 REGENXBIO Announces Presentation at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference 08/03/22 REGENXBIO Reports Second Quarter 2022 Financial Results and Recent Operational Highlights Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
